Med Ed Report briefs: February 2013

Share this article:
Lisa Keilty
Lisa Keilty

The economic crisis in Spain is affecting pharma funding for CME, says WentzMiller Global Services. It remains to be seen how declining government reimbursement rates in the EU will affect pharma spending for professional education, the consulting firm noted in its Dec. 2012-Jan. 2013 newsletter.

Meeting support firm Plannernet started a compliance division, PMC2. It will be led by new hire Lisa Keilty, CMP, who during her 10 years at Pfizer built its international meeting organization. She then started her own firm. In her new role, Keilty will seek to apply her knowledge of regulations to safeguard client compliance.

Physician social network QuantiaMD promoted Mike Coyne from president to CEO, and appointed Daniel Malloy as SVP, the firm said. Eric Schultz, QuantiaMD's founder and current CEO, moves to executive chairman.

Meeting Professionals International (MPI) said it was awarded a two-year agreement to co-develop sessions at the World Congress Global Medical Meetings Summit, taking place on February 28- March 1, in Philadelphia. MPI is also moderating a panel set to include meetings professionals from Daiichi Sankyo and Novartis.
Share this article:

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...